Subtyping relapsing–remitting multiple sclerosis (RRMS) patients may help predict disease progression and triage for treatment. We aimed to subtype RRMS by structural MRI investigate their clinical significances. 155 relapse-remitting MS 210 healthy controls (HC) were retrospectively enrolled with 3DT1, diffusion tensor imaging (DTI) resting-state functional MRI. Z scores of cortical deep gray ...

Introduction/Objectives: To analyse the infl uence of shortand long-term glatiramer acetate (GA) treatment on expression patterns of cell surfacebound adhesion molecules (AM) on peripheral blood mononuclear cells (PBMC) from patients with relapsing remitting multiple sclerosis (RRMS). BACKGROUND: GA is baseline therapy for the treatment of RRMS. It is known to reduce relapse frequencies and to ...

BackgroundThe latest diagnostic criteria for multiple sclerosis (MS) have revitalized the role of oligoclonal bands synthesis in cerebrospinal fluid (CSF-OCB). This study identifies predictors CSF-OCB-positivity among vivo metabolic markers subcortical gray/white matter MS patients after their first episode (CIS) and with relapsing-remitting course (RRMS).MethodsThe enrolled 13 CIS 23 RRMS pati...

Abnormal corticostriatal resting-state functional connectivity (rsFC) has been implicated in the neuropathology of multiple sclerosis. The striatum, a component of the basal ganglia, is involved in diverse functions including movement, cognition, emotion, and limbic information processing. However, the brain circuits of the striatal subregions contributing to the changes in rsFC in relapsing-re...

Interferon beta (IFN-β) therapy is one of the most commonly prescribed immunomodulatory therapies in relapsing-remitting multiple sclerosis (RRMS). A reversible cerebral vasoconstriction syndrome (RCVS), associated with IFN-β use, has been recently described. For this reason, we tested the effect of once a week intramuscular administration of IFN-β-1A on the function of cerebral vessels in a co...

We evaluated the effect of dimethyl fumarate (DMF) treatment on B-cell memory and cytokine production in 18 patients with relapsing remitting multiple sclerosis (RRMS) using peripheral blood mononuclear cells obtained prior to and at 6 months post-DMF initiation. We noted a decline in the absolute B-cell number with DMF treatment, with a preferential depletion of memory B cells and a concurrent...

multiple sclerosis (ms) is the most prevalent disease caused by the inflammatory demyelinating process that causes progressive nervous system degeneration over the time. optical coherence tomography (oct) is a non-invasive optical imaging technology, which can measure the thickness of retinal nerve fiber layer as well as the diameter of the macula. the purpose of the study is evaluation oct fin...

The introduction of interferon beta therapies more than 20 years ago marked a milestone in the treatment of relapsing-remitting multiple sclerosis (RRMS) with a significant impact on the approach to modern multiple sclerosis (MS) care. Key learnings and perspectives from the early days of disease modifying therapies in MS have improved the knowledge base of MS, need for treatment, and patient c...

BACKGROUND We compared bone mineral density (BMD) in patients with relapsing-remitting multiple sclerosis (RRMS) on interferon with that of patients with relapsing-remitting multiple sclerosis (RRMS) who were not receiving interferon and healthy age- and sex-matched controls. METHODS Overall, 30 patients with RRMS on interferon (treated patients), 30 patients with RRMS but not receiving inter...

BACKGROUND AND PURPOSE It is exceedingly difficult to differentiate benign multiple sclerosis (BMS) from relapsing-remitting multiple sclerosis (RRMS) based on clinical characteristics, neuroimaging, and cerebrospinal fluid tests. Optical coherence tomography (OCT) allows quantification of retinal structures, such as the retinal nerve fiber layer (RNFL) thickness, at the optic disc and the gang...